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Aim: The purpose of this study is to calculate radiation dose around a brachytherapy source
in  a water phantom for different seed locations or rotation the sources by the matrix sum-
mation method.
Background: Monte Carlo based codes like MCNP are widely used for performing radiation
transport calculations and dose evaluation in brachytherapy. But for complicated situations,
like  using more than one source, moving or rotating the source, the routine Monte Carlo
method for dose calculation needs a long time running.
Materials and methods: The MCNPX code has been used to calculate radiation dose around a
192Ir brachytherapy source and saved in a 3D matrix. Then, we used this matrix to evaluate
the  absorbed dose in any point due to some sources or a source which shifted or rotated in
some places by the matrix summation method.
Results: Three dimensional (3D) dose results and isodose curves were presented for 192Ir
source in a water cube phantom shifted for 10 steps and rotated for 45 and 90◦ based on the
matrix summation method. Also, we applied this method for some arrays of sources.
Conclusion: The matrix summation method can be used for 3D dose calculations for anybrachytherapy source which has moved or rotated. This simple method is very fast compared
to  routine Monte Carlo based methods. In addition, it can be applied for dose optimization
study.
© 2012 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
where radioactive seeds or sources are placed in or near the1. BackgroundRecently, the application of radioisotopes for diagnostic
and therapy has been developed very fast year by year.1–5
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Brachytherapy is an advanced cancer treatment modalityllem University, PO Box 397, Sabzevar, Iran. Tel.: +98 571 4003159;
A. Mowlavi).
tumor itself, giving a high radiation dose to the tumor while
reducing the radiation exposure in the surrounding healthy
tissues.6 192Ir source is used widely in brachytherapy to treat
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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Fig. 1 – The 3D of PPD variation in z = 0 mm plane (the 192Ir
source was located in the center of the water phantom).reports of practical oncology and 
ocalized tumors near the body site.7–9 Mowlavi et al. have cal-
ulated and reported Monte Carlo and experimental relative
ose determination for a microselectron HDR 192Ir source in a
ater phantom.7
Recently, Bahreyni Toossi et al. have published an article
elated to a matrix shift based technique for dose calculation
f GZP6 60Co as a stepping source for brachytherapy.10 They
mployed the pedep mesh tally (Type 1) of MCNPX code to
alculate absorbed dose in each mesh cell.10,11
.  Materials  and  methods
he dose distribution has been calculated around the 192Ir
ocated in the center of 30 cm × 30 cm × 30 cm water phantom
ube by using tally *F8:p of MCNPX code with less than 5% rel-
tive error.11 We  used MCNX code to calculate relative dose
s percentage deep dose (PDD) for a microselectron HDR 192Ir,
hich is described in reference article 6, in a water phantom
s arrays of main matrix dose.
Tally *F8 was evaluated in a sphere with 0.1 mm diame-
er cell for 960 in each z = 0, 0.1,. . .,  14 mm planes. Reference
oint was selected as PDD = 100 in: x = 0.21 mm,  y = 0.57 mm
nd z = 0 mm when the source is placed in the origin. Accord-
ng to the symmetry of the phantom and source geometry, we
aved the dose data in several 50 × 50 matrixes.
.  Results  and  discussion
sually, in a brachytherapy treatment plan we want to expose
n area inside the tumor to give a high radiation speciﬁc dose
hile reducing radiation exposure in the surrounding healthy
issues.12–19 Treatments may be delivered at a high dose rate
HDR) or a low dose rate (LDR) sources. To achieve this aim; the
ource location and time of exposure were varied in HRD like
92Ir and 137Cs sources.16,17 For LDR sources like 125I, 103Pd, the
eeds may be put inside the tumor for ever in different places
ith different activity.18,19 The physician may also insert the
adioactive material manually through a delivery device and
emove the material and delivery device when the treatment
s done. For more  than one source or seed, dose calculation by
he Monte Carlo method needs a long time. Therefore, using
he matrix summation method is a fast and easy way to obtain
ose results from many  sources or seeds.
Fig. 1 shows the 3D PPD variation in z = 0 mm plane. Shifting
f the main matrix can be done by 0.21 mm step in the x-axis
irection and 0.20 mm step in the y-axis direction and 0.1 mm
Fig. 2 – The shift of matrix 2 unistep in the z direction. According to the activity or time of
exposure and location of sources, each matrix was generated
by shifting of the origin matrix. Fig. 2 shows the 2 units shift
of the matrix in the x and y directions. We considered adding
more  arrays for the shifted matrix to be zero (the ﬁrst and the
second columns and rows in Fig. 2). We  must mention that the
values of these arrays are small because they are far from the
source and out of the tumor region. Therefore, we  plan to ﬁnd
them by extrapolation in further development of the method.
The PPD result of 10 matrixes summation is shown in Fig. 3-
a; where each matrix was shifted one step (0.21 mm)  relative
to the previous matrix in the x direction axis in z = 0 mm plane.
The isodose curve for different PDD corresponding to the data
of Fig. 3-a is presented in Fig. 3-b. This situation is like moving
the source with a constant speed in the tumor.
Furthermore, we  considered the matrix rotation role for the
sources with different angles. Fig. 4 shows the PDD variation in
the xy plane and its isodose curves, when two  sources located
in two different directions with angle of 45◦. The same result
is presented in Fig. 5 where the sources make a 90◦ angle. It
can be seen that by shifting and rotating of the main matrix
and summation method, we can obtain any isodose plan.
We applied the matrix summation technique for different
arrays of sources. Figs. 6–8 show the 3-D PPD variation and the
isodose curves for square, triangle and circle arrays of sources,
respectively. The method can be used easily for any array of
sources with different activity or time of exposure.
ts in the x and y directions.
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Fig. 3 – (a) The summation of 10 matrixes in z = 0 mm plane, each matrix was shifted one step (0.21 mm)  relative to the
previous matrix in the x direction axis; (b) the isodose curve for different PDD.
Fig. 4 – (a) The summation of two sources with 45◦ angle and (b) the isodose curve for different PDD.
Fig. 5 – (a) The summation of two sources perpendicular to each other and (b) the corresponding isodose curve for different
PDD.
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Fig. 6 – (a) The 3-D PDD variation for a square array of sources and (b) the isodose curves (the red cycles show the positions
of 9 sources).
Fig. 7 – (a) The 3-D PDD variation for a triangle array of sources and (b) the isodose curves (the red cycles show the positions
of 6 sources).
Fig. 8 – (a) The 3-D PDD variation for a circle array of sources and (b) the isodose curves (the red cycles show the positions of
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t sources).
.  Conclusion
he Monte Carlo method is used to provide accurate radia-
ion dose estimates in brachytherapy. While this method is
ore  accurate than commonly used analytical dose calcu-
ations, it is computationally intense. Therefore, by applying
he matrix summation method to dose result of Monte Carlocalculation, we reduced the time of computing and increased
the accuracy of the result for dose calculation from the same
sources. We  can consider the shifting and rotating of the
source or both of them in the matrix summation method
and evaluate the dose summation in a simple way. This
method can be applied for any HDR and LDR brachytherapy
sources. In addition, it can be applied for dose optimizations
study.
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